TNDM

Tandem Diabetes Care Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↓ 4/10
  • Value↓ 2/10
Tandem Diabetes Care sales and earnings growth
TNDM Growth
Neutral
  • Revenue Y/Y↑ 7.93%
  • EPS Y/Y↓ -106.80%
  • FCF Y/Y↓ -694.09%
Tandem Diabetes Care gross and profit margin trends
TNDM Profitability
Fair
  • Gross margin ↑ 53.80%
  • EPS margin↓ -20.20%
  • ROIC 5Y↓ -15.35%
Tandem Diabetes Care net debt vs free cash flow
TNDM Risk
Fair
  • Debt / Equity↑ 2.9
  • Debt / FCF↑ 11.9
  • Interest coverage↓ -24.3

Tandem Diabetes Care stock volatility is in-line with the overall market. We give it a Fair risk rating.

More Medical Devices stocks ↗